Home › Sjögren's Disease › North Carolina › Charlotte
Sjögren's Disease clinical trials in Charlotte, NC
4 studies for Sjögren's Disease are looking for participants at sites in and around Charlotte (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- On Site Clinical Solutions Llc, Charlotte
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Charlotte, Charlotte
- Artiva Investigational Site Charlotte, Charlotte
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Arthritis and Osteoporosis Consultants of The Carolinas - Charlotte - 1918 Randolph Rd, Charlotte
About Sjögren's Disease
Sjögren's disease is an autoimmune disease that causes dryness of the mouth, eyes, and other parts of the body. Learn how to relieve the symptoms.
More about Sjögren's Disease on MedlinePlus
Sjögren's Disease trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Tampa, FL4 studies
- Clearwater, FL4 studies
- Cicero, IL4 studies
- Arlington, TX4 studies
- Oklahoma City, OK3 studies
- Memphis, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
- Orlando, FL3 studies
Other studies in Charlotte
- Cancer (all types)29 studies
- Breast Cancer22 studies
- Non-Small Cell Lung Cancer22 studies
- Multiple Myeloma21 studies
- Acute Myeloid Leukemia18 studies
- Ovarian Cancer16 studies
- Obesity16 studies
- Colorectal Cancer15 studies
- Overweight15 studies
- Metastatic Cancer12 studies
- Heart Failure12 studies
- Head and Neck Squamous Cell Carcinoma11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.